[6-K] JX Luxventure Limited Common Stock Current Report (Foreign Issuer)

Rhea-AI Filing Summary

On July 27, 2025, JX Luxventure Group Inc.’s wholly-owned subsidiary, Jin Xuan (Hainan) Holding Co., Ltd. (“JX Hainan”), executed a 2025 Strategic Cooperation Framework Agreement with Qingxiang (Hainan) Cross-Border E-Commerce Co., Ltd. (“HCBEC”). Under the agreement, HCBEC commits to purchase not less than US$15 million of cross-border products supplied by JX Hainan, covering duty-free skincare, health supplements and lifestyle goods.

The company furnished the English translation of the agreement as Exhibit 10.1 and a related press release dated July 29, 2025 as Exhibit 99.1 in this Form 6-K. Beyond the minimum purchase value, no additional financial terms, delivery schedule or margin information are disclosed. The filing contains no earnings data or updated guidance.

• Form: 6-K (foreign private issuer)
• Minimum purchase commitment: US$15 million
• Date of agreement: 27 Jul 2025; press release: 29 Jul 2025

Positive

• US$15 million minimum purchase commitment from HCBEC provides potential revenue visibility for the 2025 period.
• Strategic partnership reinforces company presence in duty-free and cross-border e-commerce niches.

Negative

• No disclosure of margins, timelines or enforceability, leaving earnings impact uncertain.
• Framework nature implies the agreement may be non-binding, introducing execution risk.

Insights

Financial Analyst

TL;DR: US$15M guaranteed purchase boosts potential top line; impact positive but size, margin and execution risks remain.

The framework agreement offers at least US$15 million in future product sales, welcome for a company that has sought to scale its cross-border e-commerce segment. As the commitment is on the customer side, revenue recognition should follow delivery, providing visibility to cash flows once orders commence. However, the filing omits duration, pricing and profit margins, preventing assessment of earnings impact. Investors should watch for subsequent definitive contracts, fulfillment progress and whether volumes extend beyond the minimum.

Risk Analyst

TL;DR: Agreement is non-binding framework; limited disclosures leave execution, counter-party and concentration risks unresolved.

While the purchase commitment headline is sizable, the document is a framework, not a definitive sales contract. Absence of penalty clauses, payment terms or timeline suggests potential variability. Dependence on a single buyer for a large order could introduce cash-flow concentration risk. Lack of shipping or regulatory details in duty-free categories also warrants caution. Overall effect is neutral until contract terms and execution evidence emerge.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF THE

SECURITIES EXCHANGE ACT OF 1934

For the month of July 2025

(Report No. 2)

Commission File Number 001-35715

JX Luxventure Group Inc.

(Translation of registrant’s name into English)

Bin Hai Da Dao No. 270

Lang Qin Wan Guo Ji Du Jia Cun Zong He Lou

Xiu Ying District

Haikou City, Hainan Province 570100

People’s Republic of China

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

On July 27, 2025, Jin Xuan (Hainan) Holding Co., Ltd. (“JX Hainan”), a wholly-owned subsidiary of JX Luxventure Group Inc. (the “Company”), entered into a 2025 Strategic Cooperation Framework Agreement (the “Agreement”) with Qingxiang (Hainan) Cross-Border E-Commerce Co., Ltd. (“HCBEC”). Pursuant to the Agreement, HCBEC will commit to purchasing of not less than $15,000,000 in cross-border products supplied by JX Hainan, encompassing duty-free skincare, health supplements, and lifestyle goods. An English translation of the Agreement is filed herewith as Exhibit 10.1.

On July 29, 2025, the Company issued a press release with respect to the Agreement, which is furnished herewith as Exhibit 99.1.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: July 29, 2025	JX Luxventure Group Inc.
	By:	/s/ Sun Lei
		Sun Lei Chief Executive Officer

2

EXHIBIT INDEX

Exhibit Number		Description
10.1		2025 Strategic Cooperation Framework Agreement
99.1		Press Release

3

FAQ

What did JXJT announce in its July 2025 Form 6-K?

The filing discloses a 2025 Strategic Cooperation Framework Agreement under which HCBEC will purchase at least US$15 million of products from JX Hainan.

How much product is HCBEC committed to purchase from JX Luxventure's subsidiary?

HCBEC committed to buying not less than US$15 million in cross-border products.

Which product categories are included in the agreement?

The minimum purchase covers duty-free skincare, health supplements and lifestyle goods supplied by JX Hainan.

When was the agreement signed and when was it announced?

The agreement was signed on 27 July 2025, and a press release was issued on 29 July 2025.

Does the filing disclose profit margins or a delivery schedule?

No. The Form 6-K only specifies the US$15 million minimum purchase value; margins, schedules and penalties are not provided.